IL41034A - 6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them - Google Patents

6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them

Info

Publication number
IL41034A
IL41034A IL41034A IL4103472A IL41034A IL 41034 A IL41034 A IL 41034A IL 41034 A IL41034 A IL 41034A IL 4103472 A IL4103472 A IL 4103472A IL 41034 A IL41034 A IL 41034A
Authority
IL
Israel
Prior art keywords
alkyl
carbon
compound according
compound
benzodiazepines
Prior art date
Application number
IL41034A
Other languages
English (en)
Other versions
IL41034A0 (en
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of IL41034A0 publication Critical patent/IL41034A0/xx
Priority to IL44720A priority Critical patent/IL44720A/xx
Priority to IL44888A priority patent/IL44888A/xx
Publication of IL41034A publication Critical patent/IL41034A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IL41034A 1971-12-09 1972-12-08 6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them IL41034A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL44720A IL44720A (en) 1972-12-08 1974-04-26 5-phenyl-6-aza-7-amino-1,2-dihydro-3h1,4-benzodiazepin-2-one derivatives,their preparation and pharmaceutical compositions containing them
IL44888A IL44888A (en) 1972-12-08 1974-05-23 6-aza-3h-1,4-benzodiazepines,their preparation and pharmacceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1060471A AT333284B (de) 1971-12-09 1971-12-09 Verfahren zur herstellung von neuen 6-aza-3h-1,4-benzodiazepinen, deren optischen isomeren und deren salzen

Publications (2)

Publication Number Publication Date
IL41034A0 IL41034A0 (en) 1973-02-28
IL41034A true IL41034A (en) 1976-10-31

Family

ID=3623479

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41034A IL41034A (en) 1971-12-09 1972-12-08 6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
JP (4) JPS569509B2 (ru)
AR (3) AR201201A1 (ru)
AT (4) AT333284B (ru)
AU (1) AU473253B2 (ru)
BE (1) BE792541A (ru)
CH (4) CH603644A5 (ru)
CS (1) CS212736B2 (ru)
DD (1) DD105448A5 (ru)
DE (1) DE2259471C2 (ru)
DK (1) DK138425B (ru)
EG (1) EG10918A (ru)
ES (2) ES409089A1 (ru)
FI (1) FI54710C (ru)
FR (1) FR2162482B1 (ru)
GB (1) GB1400755A (ru)
HU (1) HU169468B (ru)
IL (1) IL41034A (ru)
IT (1) IT1035053B (ru)
NL (1) NL171986C (ru)
NO (1) NO137094C (ru)
PL (3) PL89682B1 (ru)
RO (4) RO65264A (ru)
SE (1) SE404803B (ru)
SU (4) SU468423A3 (ru)
YU (2) YU305972A (ru)
ZA (1) ZA728497B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364636C2 (de) * 1973-12-24 1982-11-04 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Benzoyl-6-chlor-3-nitro-pyridinen
ATE7295T1 (de) * 1980-01-16 1984-05-15 Lacer, S.A. 2-halo-pyridine, ihre herstellung und pharmazeutische zusammensetzungen.
JPS60132610A (ja) * 1983-12-20 1985-07-15 Japan Organo Co Ltd 汚泥脱水装置
JPS6219221A (ja) * 1985-07-16 1987-01-28 Chiyoda Chem Eng & Constr Co Ltd 原液中の微細粒子を除去する濾過方法と濾過装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314941A (en) * 1964-06-23 1967-04-18 American Cyanamid Co Novel substituted pyridodiazepins
US3523939A (en) * 1967-07-03 1970-08-11 Hoffmann La Roche 5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation

Also Published As

Publication number Publication date
SU674675A3 (ru) 1979-07-15
AR201201A1 (es) 1975-02-21
JPS5744678B2 (ru) 1982-09-22
RO65263B (ro) 1983-06-30
ES409090A1 (es) 1975-10-16
AR200309A1 (es) 1974-10-31
CH594665A5 (ru) 1978-01-13
SE404803B (sv) 1978-10-30
FR2162482B1 (ru) 1976-03-05
JPS5742638B2 (ru) 1982-09-09
FI54710B (fi) 1978-10-31
YU305972A (en) 1982-02-28
SU468423A3 (ru) 1975-04-25
PL89682B1 (en) 1976-12-31
JPS55147282A (en) 1980-11-17
AU473253B2 (en) 1976-06-17
DD105448A5 (ru) 1974-04-20
BE792541A (fr) 1973-06-08
SU564809A3 (ru) 1977-07-05
ATA1060471A (de) 1976-03-15
JPS4864096A (ru) 1973-09-05
NL171986C (nl) 1983-06-16
AT333284B (de) 1976-11-10
ATA902274A (de) 1976-02-15
CH603644A5 (ru) 1978-08-31
GB1400755A (en) 1975-07-23
NL171986B (nl) 1983-01-17
AT332878B (de) 1976-10-25
NO137094C (no) 1977-12-28
DE2259471A1 (de) 1973-06-14
IL41034A0 (en) 1973-02-28
AT332877B (de) 1976-10-25
JPS5742639B2 (ru) 1982-09-09
ZA728497B (en) 1973-09-26
FI54710C (fi) 1979-02-12
ES409089A1 (es) 1975-10-16
PL91876B1 (en) 1977-03-31
DK138425B (da) 1978-09-04
JPS569509B2 (ru) 1981-03-02
AT338798B (de) 1977-09-12
NO137094B (no) 1977-09-19
ATA902174A (de) 1976-02-15
AR203311A1 (es) 1975-08-29
HU169468B (ru) 1976-11-28
AU4993172A (en) 1974-06-13
RO65264A (fr) 1979-08-15
PL91828B1 (en) 1977-03-31
NL7216621A (ru) 1973-06-13
DE2259471C2 (de) 1982-08-19
JPS5625180A (en) 1981-03-10
CS212736B2 (en) 1982-03-26
DK138425C (ru) 1979-02-12
JPS5625181A (en) 1981-03-10
CH605946A5 (ru) 1978-10-13
IT1035053B (it) 1979-10-20
CH603645A5 (ru) 1978-08-31
RO67345A (ro) 1980-07-15
SU574156A3 (ru) 1977-09-25
FR2162482A1 (ru) 1973-07-20
RO62312A (fr) 1977-12-15
RO65263A (ro) 1983-07-07
YU116881A (en) 1984-02-29
EG10918A (en) 1981-12-31
ATA902074A (de) 1977-01-15

Similar Documents

Publication Publication Date Title
ES8703876A1 (es) Un procedimiento para la preparacion de derivados de purina.
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
HUT41759A (en) Process for producing new pharmaceutical composition containing ipriflavone in form of cyclodextrine inclusion complex
HUT38256A (en) Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts
GEP19960316B (en) Method for Production of Diazabicyclo [3,3,1] nonanes
EP0034473A3 (en) Substituted imidazoles, their preparation, pharmaceutical compositions containing the same and their use in therapy
ES8500948A1 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES8307496A1 (es) Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
ES8502099A1 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
ES8606297A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas
IL41034A (en) 6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them
GB1480836A (en) Physiologically active xanthine derivatives and compositions containing them
GB1043049A (en) Benzdiaz [1,4] epinone derivatives, a process for the manufacture thereof and pharmaceutical preparations containing same
ES8501772A1 (es) Procedimiento de preparacion de nuevos derivados de la nitrosourea
GB1519210A (en) Antiarrythmic compositions containing pyrrolidinyl derivatives
ES426040A1 (es) Procedimiento de preparacion de esteres cicloalquil-alqui- licos de acidos que tienen el esqueleto del eburnano.
MY111121A (en) 15,15- dialkyl-substituted derivatives of estradiol.
GB1488995A (en) Compositions containing anti-androgenic compounds
ES477257A1 (es) Un procedimiento para preprarar derivados de isoquinoleina.
ES8306593A1 (es) Procedimiento de preparar agentes farmaceuticos administra- bles por via topica
GB1312205A (en) Method and composition for lowering blood pressure
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
GB2021111A (en) Nitrofuryl-vinylene-thiazole N-oxides as antitumour agents
ES342394A1 (es) Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2).
US3821409A (en) Method of treatment